A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Zhengye Biotechnology Holding Limited ZYBT
Weak (graded 2026-07-21, not re-checked) broader-coverage candidate · Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations.
On FrontierLab's discovery record since 2026-07-20 (4 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-21), not the curated Frontier signal.
⚡ Surfaced on a price move — momentum is where to look, not a buy signal. The move that surfaced this name does not make it a good entry.
⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.
Key quality signals
| Revenue growth (YoY) | — |
|---|---|
| Gross margin | 8.3% |
| Gross profits / assets | 0.04 |
| Rule of 40 | — |
| Net margin | -77% |
| Cash runway (months) | — |
| PEG | — |
| Price / sales | 1.8 |
Quality checklist
- ✗ Gross profits / assets — 0.04 (pass ≥ 0.33)
- ✗ Gross margin — 8.3% (pass ≥ 60%)
- ✓ Cash generation
Fundamentals — snapshot as of 2026-07-21
| Stage | Established |
|---|---|
| Share issuance (YoY) | — |
| Moat | — |
| TAM | — |
| P/E (trailing) | — |
| EPS (trailing) | $-3.92 |
| Burn multiple | — |
| Gross-margin trend (pts) | — |
| Cash / assets | 0.12 |
| Net debt / EBITDA | — |
| Statements as of | Q4 FY2025 · filed 2026-04-28 |
Momentum context — a snapshot from 2026-07-21, not current
| Price at surface | $8.01 (as of 2026-07-21) |
|---|---|
| 52-week range | $0.616 – $13.08 |
| % off 52-wk high | -38.8% |
| RSI (14) | 97 |
| Relative volume | 16.3× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-07-21 (end-of-day). How grades are computed →